Ke H - Search Results

1

3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studies.

Shi H, Rath EM, Lin RCY, Sarun KH, Clarke CJ, McCaughan BC, Ke H, Linton A, Lee K, Klebe S, Maitz J, Song K, Wang Y, Kao S, Cheng YY. Shi H, et al. Among authors: ke h. Front Oncol. 2022 Aug 26;12:973576. doi: 10.3389/fonc.2022.973576. eCollection 2022. Front Oncol. 2022. PMID: 36091141 Free PMC article.

2

The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region.

Ke H, Kao S, Lee K, Takahashi K, Goh HP, Linton A. Ke H, et al. Asia Pac J Clin Oncol. 2022 Jun;18(3):177-190. doi: 10.1111/ajco.13611. Epub 2021 Jun 23. Asia Pac J Clin Oncol. 2022. PMID: 34161674 Review.

3

Malignant Peritoneal Mesothelioma With EWSR1-ATF1 Fusion: A Case Report.

Ke H, Gill AJ, McKenzie C, Kench JG, Chan RCF, Pavlakis N, Fulham M, Koh C, Kao S. Ke H, et al. JTO Clin Res Rep. 2021 Oct 11;2(11):100236. doi: 10.1016/j.jtocrr.2021.100236. eCollection 2021 Nov. JTO Clin Res Rep. 2021. PMID: 34766064 Free PMC article.

4

Hyland RA, Chrzanowska A, Hannaford-Turner K, Davis A, Ke H, Bradbury L, Nagrial A, McCaughan B, Hui R, van Zandwijk N, Takahashi K, Kao SC. Hyland RA, et al. Among authors: ke h. Asia Pac J Clin Oncol. 2022 Oct;18(5):e448-e455. doi: 10.1111/ajco.13664. Epub 2022 Jan 31. Asia Pac J Clin Oncol. 2022. PMID: 35100476

5

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma.

Davis A, Ke H, Kao S, Pavlakis N. Davis A, et al. Among authors: ke h. Lung Cancer (Auckl). 2022 Mar 2;13:1-12. doi: 10.2147/LCTT.S288535. eCollection 2022. Lung Cancer (Auckl). 2022. PMID: 35264891 Free PMC article. Review.

6

Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis.

Shi H, Zhang L, Yu TK, Zhuang L, Ke H, Johnson B, Rath E, Lee K, Klebe S, Kao S, Qin KL, Pham HNT, Vuong Q, Cheng YY. Shi H, et al. Among authors: ke h. Front Oncol. 2023 Jul 5;13:1162027. doi: 10.3389/fonc.2023.1162027. eCollection 2023. Front Oncol. 2023. PMID: 37476375 Free PMC article.

7

Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.

Ke H, Kao S, van Zandwijk N, Rasko JEJ, Yeo D. Ke H, et al. Lung Cancer. 2024 Jun;192:107829. doi: 10.1016/j.lungcan.2024.107829. Epub 2024 May 22. Lung Cancer. 2024. PMID: 38810528 Free article.

8

Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibody.

Ke H, Yang T, Zhang F, Chen C, Wang J, Liu J, An X, Xiong L, He X, Zhang L, Li QX. Ke H, et al. Sci Rep. 2024 Nov 15;14(1):28201. doi: 10.1038/s41598-024-79865-3. Sci Rep. 2024. PMID: 39548213 Free PMC article.

9

Two-stage carbon sequestration by Haematococcus pluvialis: Integrated research from small-scale to pilot-scale cultivation and data quality monitoring.

Guo S, Li F, Wang J, Zhou H, Yuan Z, Yang R, Ke H, Chen H, Wang C, Cai M. Guo S, et al. Among authors: ke h. Bioresour Technol. 2024 Nov 13:131828. doi: 10.1016/j.biortech.2024.131828. Online ahead of print. Bioresour Technol. 2024. PMID: 39547301

10

Stair climbing outperforms gait speed in predicting postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: A prospective study.

He CH, Li ZZ, Ke HW, Zhai WB, Yan XL, Xi WT, Wu GF, Zheng YY, Shen X, Huang DD. He CH, et al. Among authors: ke hw. Eur J Surg Oncol. 2024 Nov 9;51(1):109378. doi: 10.1016/j.ejso.2024.109378. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39547133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,542 results

Search Page

Filters